8-K - 8-K - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) () - 1.01 / 2.03 / 3.02 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001213900-26-043519
Filing Date: 2026-04-14
Accepted: 2026-04-14 16:01:08
Documents: 12
Period of Report: 2026-04-08
Items: Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: Financial Statements and Exhibits
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK : 0001870404 (see all company filings) EIN. : 871088814 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 26860816 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | CURRENT REPORT | ea0286319-8k_cero.htm iXBRL | 8-K
2 | XBRL SCHEMA FILE | cero-20260408.xsd | EX-101.SCH
3 | XBRL DEFINITION FILE | cero-20260408_def.xml | EX-101.DEF
4 | XBRL LABEL FILE | cero-20260408_lab.xml | EX-101.LAB